000300649 001__ 300649
000300649 005__ 20250427020305.0
000300649 0247_ $$2doi$$a10.3389/fcimb.2025.1599910
000300649 0247_ $$2pmid$$apmid:40264935
000300649 0247_ $$2pmc$$apmc:PMC12011835
000300649 0247_ $$2altmetric$$aaltmetric:175943214
000300649 037__ $$aDKFZ-2025-00860
000300649 041__ $$aEnglish
000300649 082__ $$a610
000300649 1001_ $$aBeddows, Simon$$b0
000300649 245__ $$aEditorial: Papillomaviruses, immunity, and tumour development.
000300649 260__ $$aLausanne$$bFrontiers Media$$c2025
000300649 3367_ $$2DRIVER$$aarticle
000300649 3367_ $$2DataCite$$aOutput Types/Journal article
000300649 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1745561400_21577$$xEditorial
000300649 3367_ $$2BibTeX$$aARTICLE
000300649 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300649 3367_ $$00$$2EndNote$$aJournal Article
000300649 500__ $$a#LA:D335#
000300649 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000300649 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300649 650_7 $$2Other$$aHPV
000300649 650_7 $$2Other$$aimmunity
000300649 650_7 $$2Other$$ainfection
000300649 650_7 $$2Other$$apapillomaviruses
000300649 650_7 $$2Other$$atumour development
000300649 7001_ $$aKann, Hanna$$b1
000300649 7001_ $$0P:(DE-HGF)0$$aMariz, Filipe Colaço$$b2$$eLast author
000300649 773__ $$0PERI:(DE-600)2619676-1$$a10.3389/fcimb.2025.1599910$$gVol. 15, p. 1599910$$p1599910$$tFrontiers in Cellular and Infection Microbiology$$v15$$x2235-2988$$y2025
000300649 909CO $$ooai:inrepo02.dkfz.de:300649$$pVDB
000300649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000300649 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000300649 9141_ $$y2025
000300649 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT CELL INFECT MI : 2022$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-12-06T06:41:59Z
000300649 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-12-06T06:41:59Z
000300649 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-12-06T06:41:59Z
000300649 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-12-06T06:41:59Z
000300649 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT CELL INFECT MI : 2022$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
000300649 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
000300649 9202_ $$0I:(DE-He78)D335-20160331$$kD335$$lTumorvirus-spez. Vakzinierungsstrategie$$x0
000300649 9201_ $$0I:(DE-He78)D335-20160331$$kD335$$lTumorvirus-spez. Vakzinierungsstrategie$$x0
000300649 980__ $$ajournal
000300649 980__ $$aVDB
000300649 980__ $$aI:(DE-He78)D335-20160331
000300649 980__ $$aUNRESTRICTED